POSTER SESSION IV
Tuesday, March 27, 2007 — 1:00 PM - 4:30 PM
Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
1
A Mouse Model of Basal-Like Breast Carcinoma with Metaplastic Elements
(192)
JS Reis-Filho, A McCarthy, K Savage, A Gabriel, C Naceur, A Ashworth - Institute of Cancer Research, London, United Kingdom
Significance and Relationship between Cytokeratins, p63, β-Catenin and Matrix Metalloproteinases Expression in DMBA-Induced Mammary Tumors in Mice Fed with Fat Diet
(194)
A Ribeiro-Silva, LNZ Ramalho, FS Ramalho, SB Garcia, S Zucoloto - Ribeirão Preto School of Medicine, Ribeirão Preto, São Paulo, Brazil
EGFR Gene Amplification Is an Uncommon Event in Basal-Like Breast Carcinomas
(121)
M Flanagan, U Surti, M Chivukula, GJ Carter, DJ Dabbs, R Bhargava - Magee-Womens Hospital of UPMC, Pittsburgh, PA
E-Cadherin and P120 Catenin Expression in Basal-Like Invasive Breast Carcinoma
(92)
R Bhargava, M Chivukula, GJ Carter, DJ Dabbs - Magee-Womens Hospital of UPMC, Pittsburgh, PA
Clinical, Morphologic and Immunophenotypic Characteristics of Primary Breast Carcinomas with Brain Metastases (BM)
(100)
E Brogi, MP Murray, S Patil, M Akram, T Nehhozina, L Norton, A Seidman, LK Tan - MSKCC, NYC, NY
Basal-Like Subtype Breast Cancers in Women Older Than 40 Years of Age
(118)
CH Ersahin, M Chivukula, R Bhargava, DJ Dabbs - Magee-Women’s Hospital of UPMC, Pittsburgh, PA
CK5 Is More Sensitive Than CK5/6 in Identifying Basal-Like Mammary Duct Carcinoma by Immunohistochemistry
(163)
L Marinescu, W He, RW Cartun, D Stevens, A Ricci, Jr - Hartford Hospital, Hartford, CT
Where Were Basal-Like Mammary Duct Carcinoma Hiding Prior to the Year 2000?
(140)
W He, L Marinescu, RW Cartun, D Stevens, A Ricci - Hartford Hospital, Hartford, CT
Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-Like and Metaplastic Breast Carcinomas: A Morphological, Ultrastructural, Immunohistochemical and In Situ Hybridisation Analysis
(206)
K Savage, MBK Lambros, D Robertson, RL Jones, C Jones, A Mackay, M James, JL Hornick, EM Pereira, F Milanezi, CDM Fletcher, FC Schmitt, A Ashworth, JS Reis-Filho - CR, London, United Kingdom; ICR, Sutton, United Kingdom; Harvard Medical School, Boston, MA; Sao Paulo, Brazil; Porto, Portugal
The Differential Regulation of p16 and Human Telomerase Reverse Transcriptase May Contribute to the Clinically More Aggressive Behavior of Breast Carcinomas with the Basal-Like Phenotype
(193)
A Ribeiro-Silva, S Zucoloto - Ribeirão Preto School of Medicine, Ribeirão Preto, São Paulo, Brazil
Outcome of Neoadjuvant Chemotherapy in Basal-Like Breast Carcinoma: Tissue Microarray Study
(153)
JY Kim, DH Shin, KU Choi, HW Kim, HS Kwak, YT Bae, MY Sol - School of Medicine, Pusan National University, Busan, Republic of Korea
Comparison of the Sorlie-Based Immunohistochemistry Molecular Classification and Oncotype-Dx™ Recurrence Score: High Recurrence Score Neoplasms Are Comprised of Several Molecular Group Tumor Types
(233)
M Young, NS Goldstein - William Beaumont Hospital, Royal Oak, MI
Race, Body Mass Index, and the Immunophenotype of Triple Negative Breast Cancer
(159)
JC Lee, JL Westrup, LA Stead, CL Rosenberg, TC King - Boston University School of Medicine, Boston, MA
Lobulitis in Non Neoplastic Breast Tissue from Breast Cancer Patients Is Associated with Phenotypes That Are Commonly Seen in Hereditary Breast Cancer
(218)
S Vanderwerf, L Varghese, C Sweeney, C Blair, E Gulbahce - U of MN, Minneapolis; U of UT, Salt Lake City
Mammary Lobules, Ducts and Usual Hyperplasia: An Immunohistochemical Analysis for Basal and Luminal Cell Types
(158)
HJ Lee, K Donev, U Raju - Henry Ford Hospital, Detroit, MI
Clinicopathological Features of Neuroendocrine Carcinomas of the Breast
(157)
S La Rosa, S Casnedi, C Riva, F Sessa, C Capella - Ospedale di Circolo and University of Insubria, Varese, Italy
Invasive Breast Carcinoma in Young Patients: Phenotypes and Correlation with Cell Cycle Proteins and Survival
(185)
M Planelles, FI Aranda, M Niveiro, G Peiro, A Abuomar - Hospital General de Alicante, Alicante, Spain
Prognostic Markers in Estrogen, Progesterone and Her-2/neu Negative Invasive Breast Carcinomas
(196)
RS Ricketts-Loriaux, CN Otis, E Resetkova, N Sneige - M.D. Anderson Cancer Center, Houston, TX; Baystate Medical Center, Springfield, MA
button next to any title to add to Itinerary Planner...
Add
